In furtherance of its mission and in order to respond to the inquiries it has received, Plaintiff made a number of requests to NIH pursuant to the Freedom of Information Act (5 U.S.C. §552, as amended) (“FOIA”) for documents regarding COVID-19 and a potential COVID-19 vaccine, including a request for “all safety and efficacy data and information regarding mRNA1273, including from the Phase I clinical trial of this experimental vaccine.” While NIH granted expedited processing for this request, NIH has failed to further respond to this and all the other related requests submitted by ICAN as required under FOIA.
Comments are closed.
|
Archives
March 2021
|